person reading

About Novartis AG - ADR - Company Information, Overview, History and Profile

What does Novartis AG - ADR do?

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG - ADR Management structure

All Gross Remunerations are in CHF
Dr. Vasant Narasimhan
Chief Executive Officer
14.19 M
2024
Gross Remuneration
Year
Mr. Harry Kirsch
Chief Financial Officer
6.27 M
2024
Gross Remuneration
Year
Dr. Patrick Horber, M.D.
President, International
5.89 M
2024
Gross Remuneration
Year
Mr. Victor Bulto
President, US
5.77 M
2024
Gross Remuneration
Year
Dr. Steffen Lang, PhD
President, Operations
-
2024
Gross Remuneration
Year
Dr. Klaus Moosmayer, PhD
Chief Ethics, Risk and Compliance Officer
-
2024
Gross Remuneration
Year

Novartis AG - ADR Board of directors

All Gross Remunerations are in CHF
Mr. Joerg Reinhardt, PhD
Chairman of the Board
3.8 M
2024
Gross Remuneration
Year
Mr. Simon E Moroney, D.Phil.
Vice Chairman of the Board
460 K
2024
Gross Remuneration
Year
Ms. Elizabeth Doherty
Independent Director
450 K
2024
Gross Remuneration
Year
Ms. Bridgette P. Heller
Independent Director
430 K
2024
Gross Remuneration
Year
Mr. Ton Buechner
Independent Director
424.68 K
2024
Gross Remuneration
Year
Mr. Patrice Bula
Lead Independent Director
413.78 K
2024
Gross Remuneration
Year